Riken Vitamin Co., Ltd. (TYO:4526)

Riken Vitamin Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	18,666	23,384	19,155	17,302	19,230	14,538
Cash & Short-Term Investments	18,666	23,384	19,155	17,302	19,230	14,538
Cash Growth	-7.61%	22.08%	10.71%	-10.03%	32.27%	-12.35%
Receivables	25,384	23,114	20,116	18,715	18,311	19,347
Inventory	19,348	18,581	17,735	15,076	14,287	16,902
Other Current Assets	1,433	1,442	1,120	1,697	1,498	1,728
Total Current Assets	64,831	66,521	58,126	52,790	53,326	52,515
Property, Plant & Equipment	24,635	23,382	23,637	25,428	27,861	28,003
Long-Term Investments	20,704	27,355	22,338	23,267	24,294	20,233
Other Intangible Assets	977	976	645	698	681	667
Long-Term Deferred Tax Assets	-	540	475	474	371	429
Other Long-Term Assets	5,529	2	2	2	-	2
Total Assets	116,676	118,776	105,223	102,660	106,535	101,853
Accounts Payable	9,482	9,900	8,257	7,696	6,577	7,241
Accrued Expenses	488	5,618	4,808	4,656	4,841	4,876
Short-Term Debt	2,893	11,938	3,306	3,674	23,920	9,276
Current Income Taxes Payable	518	1,352	1,163	226	1,307	748
Other Current Liabilities	7,841	2,309	1,390	1,969	16,167	14,050
Total Current Liabilities	21,222	31,117	18,924	18,221	52,812	36,191
Long-Term Debt	7,741	4,115	11,254	13,860	451	13,870
Long-Term Deferred Tax Liabilities	-	4,626	1,579	2,038	4,285	2,607
Other Long-Term Liabilities	7,310	1,979	1,866	1,794	2,095	2,191
Total Liabilities	36,559	42,134	33,853	36,122	59,862	55,066
Common Stock	2,537	2,537	2,537	2,537	2,537	2,537
Additional Paid-In Capital	2,470	2,466	2,466	3,072	3,079	3,079
Retained Earnings	68,345	65,290	58,729	65,426	45,230	48,259
Treasury Stock	-7,949	-7,954	-1,633	-13,785	-13,804	-13,809
Comprehensive Income & Other	14,682	14,273	9,245	9,269	9,114	6,231
Total Common Equity	80,085	76,612	71,344	66,519	46,156	46,297
Minority Interest	32	30	26	19	517	490
Shareholders' Equity	80,117	76,642	71,370	66,538	46,673	46,787
Total Liabilities & Equity	116,676	118,776	105,223	102,660	106,535	101,853
Total Debt	10,634	16,053	14,560	17,534	24,371	23,146
Net Cash (Debt)	8,032	7,331	4,595	-232	-5,141	-8,608
Net Cash Growth	7.39%	59.54%	-	-	-	-
Net Cash Per Share	261.03	224.76	140.07	-7.07	-156.77	-262.54
Filing Date Shares Outstanding	30.36	30.36	32.81	32.8	32.79	32.79
Total Common Shares Outstanding	30.36	30.36	32.81	32.8	32.79	32.79
Working Capital	43,609	35,404	39,202	34,569	514	16,324
Book Value Per Share	2637.79	2523.80	2174.34	2027.81	1407.42	1411.83
Tangible Book Value	79,108	75,636	70,699	65,821	45,475	45,630
Tangible Book Value Per Share	2605.61	2491.65	2154.68	2006.53	1386.66	1391.49

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.